Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Q1KP
|
||||
| Former ID |
DIB009696
|
||||
| Drug Name |
R-18893
|
||||
| Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Discontinued in Phase 2 | [1] | ||
| Company |
Janssen Pharmaceutica NV
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
[N+](=O)(c1c(NC(c2c(Cl)cccc2Cl)C(=O)N)cccc1)[O-]
|
||||
| CAS Number |
CAS 147362-54-7
|
||||
| Target and Pathway | |||||
| Target(s) | HIV reverse transcriptase | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002204) | ||||
| REF 2 | EP patent application no. 0767664, Combination therapy for hiv infection. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.